Breast cancer is
where we start.
Earlier insight changes everything. Person Health is preparing a Research Use Only blood test for breast cancer research and earlier risk identification — built on the platform, and designed to expand.
A large need, a clear gap,
and strong early direction.
A deeply personal need
Breast cancer is common, feared, and personal — and finding it earlier can change treatment, cost, and outcomes.
A clear gap
Current screening still leaves gaps. A blood-based signal offers a different, complementary way to look earlier.
A path to launch
Beginning through clinician-led, research-use channels while evidence and future clinical pathways advance.
MyBloodQ reads the whole pattern.
Most tests look for a narrow signal — one marker, one threshold. MyBloodQ reads a broader molecular pattern in blood, because the pattern can move before a single marker does.
Launching for Research Use Only — by design.
Our initial breast cancer program is launching for Research Use Only as we build evidence, clinical partnerships, and future laboratory pathways. It's an intentional first step in evidence development and market learning.
Blood-based molecular fingerprinting, beginning with breast cancer research — the first commercial expression of the platform.
A person-centered place to access testing, organize health information, and engage with guided health intelligence.
A differentiated, non-invasive breath platform — a future source of earlier signals as the platform expands.
Built to expand.
Breast cancer gets us into market. The same platform is designed to grow — the direction, without promises on timing.
Additional indications
New disease areas developed on the same platform.
Expanded health intelligence
A more complete, longitudinal picture over time.
Multi-modal diagnostics
Blood, breath, and more, read as one connected picture.
Earlier insight changes everything.
Beginning with breast cancer — and built to grow. Let's talk about what earlier insight could mean.